These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23190520)

  • 21. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hepatitis C virus on C-reactive protein and interleukin-6 in hemodialysis patients.
    Afzal N; Abbas S; Ahmed A; Arif M; Javeed K
    Iran J Kidney Dis; 2011 Jul; 5(3):182-6. PubMed ID: 21525578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between vitamin C deficiency and dialysis modalities.
    Zhang K; Dong J; Cheng X; Bai W; Guo W; Wu L; Zuo L
    Nephrology (Carlton); 2012 Jul; 17(5):452-7. PubMed ID: 22404236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients.
    Terrier N; Senécal L; Dupuy AM; Jaussent I; Delcourt C; Leray H; Rafaelsen S; Bosc JY; Maurice F; Canaud B; Cristol JP
    Hemodial Int; 2005 Apr; 9(2):159-68. PubMed ID: 16191065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients.
    Satta N; Pagano S; Montecucco F; Gencer B; ; Mach F; Kaiser L; Calmy A; Vuilleumier N
    J Infect; 2018 Feb; 76(2):186-195. PubMed ID: 29198606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
    Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
    Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
    Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
    J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.
    Amira OC; Naicker S; Manga P; Sliwa K; Mia A; Raal F; Crowther NJ; Immelman RA; Olorunju S
    Hemodial Int; 2012 Jan; 16(1):59-68. PubMed ID: 22099423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
    Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L
    J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients.
    Hsu CW; Lin JL; Lin-Tan DT; Yen TH; Chen KH
    Ther Apher Dial; 2010 Dec; 14(6):552-9. PubMed ID: 21118362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4.
    Montecucco F; Braunersreuther V; Burger F; Lenglet S; Pelli G; Carbone F; Fraga-Silva R; Stergiopulos N; Monaco C; Mueller C; Pagano S; Dallegri F; Mach F; Vuilleumier N
    Thromb Haemost; 2015 Aug; 114(2):410-22. PubMed ID: 25879306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study.
    Kollerits B; Krane V; Drechsler C; Lamina C; März W; Ritz E; Wanner C; Kronenberg F;
    J Intern Med; 2012 Dec; 272(6):592-600. PubMed ID: 22891946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
    Ames PR; Matsuura E; Batuca JR; Ciampa A; Lopez LL; Ferrara F; Iannaccone L; Alves JD
    Lupus; 2010 May; 19(6):711-6. PubMed ID: 20064910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.
    Ansari MR; Maheshwari N; Shaikh MA; Laghari MS; ; Lal K; Ahmed K
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):21-5. PubMed ID: 22237213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of serum apolipoprotein A-IV as a marker of cardiovascular disease in maintenance hemodialysis patients.
    Omori M; Watanabe M; Matsumoto K; Honda H; Hattori H; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):341-8. PubMed ID: 20609189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes.
    Asciutto G; Wigren M; Fredrikson GN; Mattisson IY; Grönberg C; Alm R; Björkbacka H; Dias NV; Edsfeldt A; Gonçalves I; Nilsson J
    Stroke; 2016 Apr; 47(4):1140-3. PubMed ID: 26965851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
    Goldstein SL; Leung JC; Silverstein DM
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the meaning of homocysteine in patients on dialysis?
    Silva de Almeida CC; Guerra DC; Vannucchi MT; Geleilete TJ; Vannucchi H; Chiarello PG
    J Ren Nutr; 2011 Sep; 21(5):394-400. PubMed ID: 21439851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases.
    Teixeira PC; Ducret A; Ferber P; Gaertner H; Hartley O; Pagano S; Butterfield M; Langen H; Vuilleumier N; Cutler P
    J Biol Chem; 2014 Oct; 289(41):28249-59. PubMed ID: 25170076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.